| Title : Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis - Williams-Herman_2008_BMC.Endocr.Disord_8_14 |
| Author(s) : Williams-Herman D , Round E , Swern AS , Musser B , Davies MJ , Stein PP , Kaufman KD , Amatruda JM |
| Ref : BMC Endocr Disord , 8 :14 , 2008 |
| Abstract : Williams-Herman_2008_BMC.Endocr.Disord_8_14 |
| ESTHER : Williams-Herman_2008_BMC.Endocr.Disord_8_14 |
| PubMedSearch : Williams-Herman_2008_BMC.Endocr.Disord_8_14 |
| PubMedID: 18954434 |
| Title : Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: a model-based approach - Xu_2008_Diabetes.Obes.Metab_10_1212 |
| Author(s) : Xu L , Man CD , Charbonnel B , Meninger G , Davies MJ , Williams-Herman D , Cobelli C , Stein PP |
| Ref : Diabetes Obes Metab , 10 :1212 , 2008 |
| Abstract : Xu_2008_Diabetes.Obes.Metab_10_1212 |
| ESTHER : Xu_2008_Diabetes.Obes.Metab_10_1212 |
| PubMedSearch : Xu_2008_Diabetes.Obes.Metab_10_1212 |
| PubMedID: 18476982 |
| Title : Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: focus on sitagliptin - Herman_2007_Clin.Pharmacol.Ther_81_761 |
| Author(s) : Herman GA , Stein PP , Thornberry NA , Wagner JA |
| Ref : Clinical Pharmacology & Therapeutics , 81 :761 , 2007 |
| Abstract : Herman_2007_Clin.Pharmacol.Ther_81_761 |
| ESTHER : Herman_2007_Clin.Pharmacol.Ther_81_761 |
| PubMedSearch : Herman_2007_Clin.Pharmacol.Ther_81_761 |
| PubMedID: 17392725 |